RUTILEA

Flextrapower (formerly known as Bonbouton) is a healthcare startup from New York City that monitors the temperature and humidity of diabetic patients’ feet to help prevent severe complications such as foot amputation. Often in the US, people have to wait several days after making an appointment to see a doctor. Therefore, by the time they see a doctor, sometimes the condition is deteriorated too much, resulting in leg amputation. The company created nano-level ultra-thin sensors that fit inside the shoes’ insoles, monitored via a smartphone app. AI can read signs that could lead to severe conditions and report them to the patient and their doctor.

Hava Health is a healthcare startup tackling nicotine dependence amongst the younger generation in the U.S. due to the spread of electric cigarettes. The electric cigarette in the U.S. is different from Japanese ones because U.S. ones can be controlled to absorb liquid nicotine. Hava’s nicotine addiction treatment device uses the same mechanism as the electric cigarettes to control the nicotine dosage vis a smartphone app so that users can gradually reduce it.
Hale Therapeutics plans to get medical device approval in the U.K. (MHRA) and USA (FDA)

Sana Health is an American startup developing “Sana” that relieves chronic pain and improves mental well-being. Sana is a portable device that provides treatment by audiovisual. It is estimated that 50 million people in the U.S. suffer from chronic pain and 10 million suffer from fibromyalgia. Users would see low pulses of light through the closed eyelids and hear sound pulses through the headphones. It measures the heart rate on the forehead. Using a smartphone app, the user can get personalized treatment depending on the current health condition. Sana Healthaim to get FDA medical device approval by the end of 2021.